Innovation Direct™ at Forefront of Marketing Campaign for Non-Invasive Blood Sugar Reading Invention

South Miami, FL, September 05, 2014 --(PR.com)-- An innovative new product designed to effectively carry out an important ongoing medical procedure, the Non-Invasive Blood Sugar Reading, has been developed by Dennerd Ovando of Cleburne, Texas. The invention's unique design enables it to leverage modern technology to eliminate the more unpleasant aspects of checking blood sugar.

The Non-Invasive Blood Sugar Reading eliminates the need for the skin of the patient to be broken in order to obtain a measurement. The product saves time and provides the patient with more overall peace of mind and less tension when having their blood sugar measured. Additionally, the Non-Invasive Blood Sugar Reading is exceedingly easy to operate. Furthermore, the Non-Invasive Blood Sugar Reading can be instrumental in detecting new diabetes cases by greatly simplifying the process of checking blood sugar. Moreover, it will be competitively priced and made from durable materials, adding to its appeal.

The inventor of the Non-Invasive Blood Sugar Reading has developed a working prototype that has been utilized with success. The Non-Invasive Blood Sugar Reading is also in Patent Pending status within the United States Patent and Trademark Office.

Mr. Ovando now seeks a third party licensee to manufacture, market, and distribute the product for him under a royalty agreement. Potential licensees in the medical accessories industry are currently being targeted as candidates to eventually commercialize the Non-Invasive Blood Sugar Reading on a worldwide basis.

In May 2014, Mr. Ovando contracted Miami, Florida-based product management services leader Innovation Direct™ to represent the Non-Invasive Blood Sugar Reading to potential licensees for a 2 year period. Innovation Direct™ obtains the maximum amount of exposure for the products that it represents through its unique and patented licensing methodology and its participation in multiple and diverse industry-leading trade shows each year. Exhibits that Innovation Direct™ has attended in recent years include the SHOT Show, the International Home and Housewares Show, the World of Concrete Show, the National Hardware Show, Licensing International, the SEMA and AAPEX Shows and the ERA D2C Convention.

Potential licensees interested in obtaining more information about the Non-Invasive Blood Sugar Reading and discussing licensing opportunities with respect to the product can contact the Manufacturer Response Department of Innovation Direct™ at (877) 991-0909 ext. 4285 or at MR@innovationdirectonline.com.